Asthma
COPD
Pulmonary
Search
Article
Blog
Company
Podcast
Product
Video
Whitepaper
Enter search phrase
Search
Asthma
Key gene protects against virus-induced asthma attacks
Researchers encourage therapies aimed at strengthening host immune pathways.
January 16, 2026
Asthma
Use of noninvasive positive pressure ventilation is rising in severe asthma cases
The treatment may significantly improve patient outcomes.
January 16, 2026
COPD
Nucala gains approval in China for COPD
The treatment continues to gain acceptance around the world, following earlier U.S. approval and European recommendation.
January 15, 2026
COPD
First patient dosed in novel COPD treatment trial
BBT002 is designed to simultaneously inhibit IL-4/IL-13 and IL-5 signaling to suppress inflammation in COPD.
January 15, 2026
Pulmonary
Developmental drug releases antibiotic to treat severe pneumonia
The engineered therapy carries medicine to lung immune cells to kill bacteria.
January 13, 2026
Pulmonary
Researchers identify neutrophils that trigger PANoptosis, acute lung injury
The discovery sheds new light on complex immune responses in sepsis and reveals a promising treatment for this life-threatening disease.
January 13, 2026
Pulmonary
FDA approves nerandomilast for adults with PPF
Progressive pulmonary fibrosis becomes the second authorized indication for the drug therapy in the United States.
January 9, 2026
Pulmonary
CS1 clears hurdle to begin dose-finding trial for PAH
The developmental drug has previously demonstrated safety, tolerability and early disease-modifying outcomes.
January 8, 2026
COPD
AI-powered ECG analysis could offer early detection of COPD
Researchers tested the effectiveness of using a deep learning network to analyze electrocardiograms to detect COPD.
January 8, 2026
COPD
Obesity, inflammation may increase the risk of COPD
Study indicates that systemic inflammation and obesity contribute to the acceleration of lung aging, raising the chances of COPD.
January 8, 2026
Asthma
Chitinase-like proteins drive airway remodeling in allergic asthma
The inflammatory biomarkers contribute to long‑term structural changes in the airways.
January 7, 2026
Asthma
Benralizumab’s role in treating eosinophilic asthma, COPD exacerbations
The biologic rapidly depletes eosinophils, offering a safer and more effective alternative.
January 7, 2026
Pulmonary
PROTHOR study evaluates patient safety in lung surgery
The large trial sought to understand how mechanical ventilation strategies affect postoperative outcomes.
December 30, 2025
COPD
Nucala receives recommendation for COPD treatment
The drug received a positive opinion from the Committee for Medicinal Products for Human Use of the European Medicines Agency.
December 30, 2025
COPD
Company launches first nebulized triple therapy for COPD
Treatment combines glycopyrronium, formoterol and budesonide into an one-unit dose.
December 30, 2025
Pulmonary
Treating pneumoconiosis with ferroptosis-targeted therapy
Inhibiting the form of cell death could improve lung fibrosis caused by dust inhalation.
December 29, 2025
Asthma
Generate:Biomedicines clinical trial tackles asthma with AI
Phase 3 trial underway to evaluate a long-acting anti-thymic stromal lymphopoietin antibody.
December 29, 2025
Asthma
Childhood asthma risk driven by RSV, maternal allergy combined
Large-scale analysis reveals the threat is more than fivefold.
December 29, 2025
Previous Page
Next Page